Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aviram

Showing results (181-190 of 267) with videos related to

Pageof 27
Sort By:
Harefuah|April 1, 1992
[Increased propensity to oxidation of LDL of hypertensives]S Keidar, C Shapira, M Kaplan, et al.
British Journal of Clinical Pharmacology|November 1, 1992
Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemiaY Levy, R Leibowitz, M Aviram, et al.
Metabolism: Clinical and Experimental|November 1, 1992
Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDLS Keidar, M Kaplan, M Rosenblat, et al.
Israel Journal of Medical Sciences|February 1, 1991
Decreased very low density lipoprotein fluidity in familial hypercholesterolemiaL Klein, M Aviram, G J Brook, et al.
Annals of Nutrition & Metabolism|September 6, 2000
Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitusY Levy, H Zaltsberg, A Ben-Amotz, et al.
Journal of Cardiovascular Risk|February 1, 1995
Protective effect of low concentrations of oxidized low-density lipoprotein on endothelial cell integrityE Wolfovitz, M Aviram, J G Brook, et al.
Metabolism: Clinical and Experimental|January 1, 1994
Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patientsE Hochgraf, Y Levy, M Aviram, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|October 1, 1995
HDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein: studies in transgenic miceT Hayek, J Oiknine, G Dankner, et al.
British Journal of Clinical Pharmacology|December 1, 1994
Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studiesS Keidar, M Aviram, I Maor, et al.
Israel Journal of Medical Sciences|May 1, 1985
Increased platelet aggregation following splenectomy in patients with myeloproliferative diseaseM Aviram, A Carter, I Tatarsky, et al.
Pageof 27

Showing results (181-190 of 267) with videos related to

Sort By:
Pageof 27
Harefuah|April 1, 1992
[Increased propensity to oxidation of LDL of hypertensives]S Keidar, C Shapira, M Kaplan, et al.
British Journal of Clinical Pharmacology|November 1, 1992
Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemiaY Levy, R Leibowitz, M Aviram, et al.
Metabolism: Clinical and Experimental|November 1, 1992
Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDLS Keidar, M Kaplan, M Rosenblat, et al.
Israel Journal of Medical Sciences|February 1, 1991
Decreased very low density lipoprotein fluidity in familial hypercholesterolemiaL Klein, M Aviram, G J Brook, et al.
Annals of Nutrition & Metabolism|September 6, 2000
Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitusY Levy, H Zaltsberg, A Ben-Amotz, et al.
Journal of Cardiovascular Risk|February 1, 1995
Protective effect of low concentrations of oxidized low-density lipoprotein on endothelial cell integrityE Wolfovitz, M Aviram, J G Brook, et al.
Metabolism: Clinical and Experimental|January 1, 1994
Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patientsE Hochgraf, Y Levy, M Aviram, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|October 1, 1995
HDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein: studies in transgenic miceT Hayek, J Oiknine, G Dankner, et al.
British Journal of Clinical Pharmacology|December 1, 1994
Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studiesS Keidar, M Aviram, I Maor, et al.
Israel Journal of Medical Sciences|May 1, 1985
Increased platelet aggregation following splenectomy in patients with myeloproliferative diseaseM Aviram, A Carter, I Tatarsky, et al.
Pageof 27